First time as a Strat-up at Europe’s biggest Photonics Trade Show
From June 27th to June 30th, 2023, our DeepEn colleagues Sergey (CEO) and Jiri (CTO) embarked on a significant journey to attend the Laser World of Photonics conference in Munich, one of Europe’s largest and most important photonics events. Their primary objective was to showcase the innovative potential of microendoscopy in the field of neurophotonics.
For Sergey, this marked his inaugural visit to a photonics convention not as a scientist but as a business leader. The two co-founders were on a mission to present DeepEn’s vision of introducing the first commercially available microendoscope for neuroscience applications. NeuroDeep® 1.0 represents an advanced laboratory setup that utilizes state-of-the-art holographic principles to facilitate microscopic imaging through an incredibly thin fiber. This technology is designed to serve as an endoscopic probe for minimally invasive imaging of living brain tissue.
Depending on the circumstances, NeuroDeep has the capacity to enable neuroscientists to achieve high-resolution or high-speed imaging of deep brain regions. This opens up possibilities for structural and functional imaging in critical areas such as the hippocampus, amygdala, or brain stem, all without the need to extract the overlying tissue.
NeuroDeep can already reliably resolve submicrometric features, such as dendritic spines, which can be imaged using commonly used fluorescence-labelling techniques. This capability can allow researchers to better observe changes caused by neurodegenerative diseases over time. To make deep brain neuron activity visible NeuroDeep can also be used for calcium imaging techniques. In the near future, DeepEn aims to tackle what is widely considered the holy grail of neuroimaging: voltage imaging, which would enable the visualization of neuron action potentials at significantly higher frequencies.
At the Laser World of Photonics in Munich, our project received substantial interest and attention. We shared a booth with colleagues from the research association Leibniz Health Technologies, and we are immensely grateful to them for providing us with this opportunity.
